Ovid Therapeutics (OVID) Asset Utilization Ratio (2021 - 2026)

Ovid Therapeutics (OVID) has reported Asset Utilization Ratio for 6 consecutive years, with 0.01 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Asset Utilization Ratio fell 91.73% year-over-year to 0.01; the trailing twelve-month figure through Jun 2026 stood at 0.01 (down 91.73% YoY), and the FY2025 full-year result was 0.06, up 1144.87% from the prior year.
• Asset Utilization Ratio retreated to 0.01 in Q2 2026 per OVID's latest filing, from 0.04 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.09 in Q3 2025 and bottomed at 0.0 in Q1 2023.
• Historically, Asset Utilization Ratio has averaged 0.02 across 5 years, with a median of 0.01 in 2025.
• The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio sank 99.19% in 2022, then soared 1738.0% in 2025.
• Over 5 years, Asset Utilization Ratio stood at 0.01 in 2022, then sank by 68.95% to 0.0 in 2023, then surged by 99.41% to 0.01 in 2024, then soared by 1062.2% to 0.07 in 2025, then tumbled by 89.75% to 0.01 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.04, and 0.07 for Q2 2026, Q1 2026, and Q4 2025 respectively.